Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$15.1M Sell
191,844
-36,680
-16% -$2.81M 0.58% 65
2019
Q1
$18.2M Sell
228,524
-52
-0% -$3.89K 0.76% 52
2018
Q4
$17.2M Sell
228,576
-17,030
-7% -$1.2M 0.79% 41
2018
Q3
$16.6M Sell
245,606
-98,578
-29% -$6.28M 0.7% 47
2018
Q2
$20.1M Buy
344,184
+195,766
+132% +$11M 0.86% 28
2018
Q1
$7.77M Buy
148,418
+24,943
+20% +$1.35M 0.4% 96
2017
Q4
$6.68M Buy
+123,475
New +$6.85M 0.36% 100

Other funds holding MRK

Delek Group's MRK Position: Q2 2019 in Review

Delek Group reduced its Merck (MRK) stake by 16% in Q2 2019, selling an estimated $2.81M and leaving 191,844 shares worth $15.1M. The position accounts for 0.58% of the portfolio, ranked #65.

Delek Group first reported a position in MRK in Q4 2017 and has held it in 7 quarters since. The position peaked at $20.1M in Q2 2018. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Delek Group held 191,844 shares of Merck worth $15.1M as of Q2 2019.
  • Delek Group sold 36,680 Merck shares in Q2 2019, an estimated $2.81M.
  • Merck made up 0.58% of Delek Group's portfolio in Q2 2019, its #65 holding.
  • Delek Group first reported a position in Merck in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Merck position peaked at $20.1M in Q2 2018.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.